اختلالات خلقی و اضطرابی در دوران بارداری و پس از زایمان (مروری بر روانپزشکی)

Mood and Anxiety Disorders During Pregnancy and Postpartum earns its important place in the literature by detailing our current understanding of the course, diagnosis, and treatment of psychiatric illness during pregnancy and postpartum, including breast-feeding—a top priority today because we now know that active maternal psychiatric illness during pregnancy and postpartum can exert long-term negative effects on child development and cause significant morbidity for the mother. In just five concise richly informative chapters, the nine distinguished contributors to Mood and Anxiety Disorders During Pregnancy and Postpartum dispel prevailing beliefs and offer invaluable guidance in treating women during pregnancy and postpartum: Course of Psychiatric Illness During Pregnancy and the Postpartum Period —Despite the enduring belief that pregnancy is a time of emotional well-being for women, emerging data show that pregnancy is instead a time of increased vulnerability to psychiatric illness. Diagnosis and Treatment of Mood and Anxiety Disorders During Pregnancy —Though the use of psychotropic medications during pregnancy and postpartum raises concerns, the accumulating data support the use of certain SSRIs/tricyclic antidepressants, especially when balanced against the risk to both mother and child of depression during pregnancy. Management of Bipolar Disorder During Pregnancy and the Postpartum Period: Weighing the Risks and Benefits —Although the onset of bipolar disorder (BP) tends to occur during women's reproductive years, surprisingly little is known about the impact of the menstrual cycle, pregnancy, postpartum, breast-feeding, and menopause on the course and treatment of bipolar disorder. Postpartum Mood Disorders —Women experience a dramatic increase in their risk of developing severe psychiatric illness during postpartum for a full year after delivery. Often overlooked, postpartum disorders must be identified and treated as early as possible to reduce the mother's risk for recurrent and treatment-refractory illness and the child's risk for long-term development problems due to the detrimental effect of maternal depression. Use of Antidepressants and Mood Stabilizers in Breast-feeding Women —This expanded clinical appraisal of the literature on antidepressant and mood stabilizer use in breast-feeding women shows that additional detailed pharmacokinetic investigations are urgently needed to enhance our understanding of nursing infant exposure and the role(s) of pharmacogenomics in determining infant exposure. Meticulously referenced and remarkably succinct, Mood and Anxiety Disorders During Pregnancy and Postpartum provides critical information about the course of illness during pregnancy and postpartum to help guide effective individualized treatment decisions-decisions that are ultimately based on the patient's wishes.

Mood and Anxiety Disorders During Pregnancy and Postpartum earns its important place in the literature by detailing our current understanding of the course, diagnosis, and treatment of psychiatric illness during pregnancy and postpartum, including breast-feeding -- a top priority today because we now know that active maternal psychiatric illness during pregnancy and postpartum can exert long-term negative effects on child development and cause significant morbidity for the mother.

In just five concise richly informative chapters, the nine distinguished contributors to Mood and Anxiety Disorders During Pregnancy and Postpartum dispel prevailing beliefs and offer invaluable guidance in treating women during pregnancy and postpartum: • Course of Psychiatric Illness During Pregnancy and the Postpartum Period -- Despite the enduring belief that pregnancy is a time of emotional well-being for women, emerging data show that pregnancy is instead a time of increased vulnerability to psychiatric illness.• Diagnosis and Treatment of Mood and Anxiety Disorders During Pregnancy -- Though the use of psychotropic medications during pregnancy and postpartum raises concerns, the accumulating data support the use of certain SSRIs/tricyclic antidepressants, especially when balanced against the risk to both mother and child of depression during pregnancy.• Management of Bipolar Disorder During Pregnancy and the Postpartum Period: Weighing the Risks and Benefits -- Although the onset of bipolar disorder (BP) tends to occur during women's reproductive years, surprisingly little is known about the impact of the menstrual cycle, pregnancy, postpartum, breast-feeding, and menopause on the course and treatment of bipolar disorder. • Postpartum Mood Disorders -- Women experience a dramatic increase in their risk of developing severe psychiatric illness during postpartum for a full year after delivery. Often overlooked, postpartum disorders must be identified and treated as early as possible to reduce the mother's risk for recurrent and treatment-refractory illness and the child's risk for long-term development problems due to the detrimental effect of maternal depression.• Use of Antidepressants and Mood Stabilizers in Breast-feeding Women -- This expanded clinical appraisal of the literature on antidepressant and mood stabilizer use in breast-feeding women shows that additional detailed pharmacokinetic investigations are urgently needed to enhance our understanding of nursing infant exposure and the role(s) of pharmacogenomics in determining infant exposure.

Meticulously referenced and remarkably succinct, Mood and Anxiety Disorders During Pregnancy and Postpartum provides critical information about the course of illness during pregnancy and postpartum to help guide effective individualized treatment decisions-decisions that are ultimately based on the patient's wishes.

Mood and Anxiety Disorders During Pregnancy and Postpartum earns its important place in the literature by detailing our current understanding of the course, diagnosis, and treatment of psychiatric illness during pregnancy and postpartum, including breast-feeding -- a top priority today because we now know that active maternal psychiatric illness during pregnancy and postpartum can exert long-term negative effects on child development and cause significant morbidity for the mother. In just five concise richly informative chapters, the nine distinguished contributors to Mood and Anxiety Disorders During Pregnancy and Postpartum dispel prevailing beliefs and offer invaluable guidance in treating women during pregnancy and postpartum: - Course of Psychiatric Illness During Pregnancy and the Postpartum Period -- Despite the enduring belief that pregnancy is a time of emotional well-being for women, emerging data show that pregnancy is instead a time of increased vulnerability to psychiatric illness.- Diagnosis and Treatment of Mood and Anxiety Disorders During Pregnancy -- Though the use of psychotropic medications during pregnancy and postpartum raises concerns, the accumulating data support the use of certain SSRIs/tricyclic antidepressants, especially when balanced against the risk to both mother and child of depression during pregnancy.- Management of Bipolar Disorder During Pregnancy and the Postpartum Period: Weighing the Risks and Benefits -- Although the onset of bipolar disorder (BP) tends to occur during women's reproductive years, surprisingly little is known about the impact of the menstrual cycle, pregnancy, postpartum, breast-feeding, and menopause on the course and treatment of bipolar disorder. - Postpartum Mood Disorders -- Women experience a dramatic increase in their risk of developing severe psychiatric illness during postpartum for a full year after delivery. Often overlooked, postpartum disorders must be identified and treated as early as possible to reduce the mother's risk for recurrent and treatment-refractory illness and the child's risk for long-term development problems due to the detrimental effect of maternal depression.- Use of Antidepressants and Mood Stabilizers in Breast-feeding Women -- This expanded clinical appraisal of the literature on antidepressant and mood stabilizer use in breast-feeding women shows that additional detailed pharmacokinetic investigations are urgently needed to enhance our understanding of nursing infant exposure and the role(s) of pharmacogenomics in determining infant exposure. Meticulously referenced and remarkably succinct, Mood and Anxiety Disorders During Pregnancy and Postpartum provides critical information about the course of illness during pregnancy and postpartum to help guide effective individualized treatment decisions-decisions that are ultimately based on the patient's wishes. __Mood and Anxiety Disorders During Pregnancy and Postpartum__In just five concise richly informative chapters, the nine distinguished contributors to __Mood and Anxiety Disorders During Pregnancy and Postpartum__ dispel prevailing beliefs and offer invaluable guidance in treating women during pregnancy and postpartum: * __Course of Psychiatric Illness During Pregnancy and the Postpartum Period__—Despite the enduring belief that pregnancy is a time of emotional well-being for women, emerging data show that pregnancy is instead a time of increased vulnerability to psychiatric illness. * __Diagnosis and Treatment of Mood and Anxiety Disorders During Pregnancy__—Though the use of psychotropic medications during pregnancy and postpartum raises concerns, the accumulating data support the use of certain SSRIs/tricyclic antidepressants, especially when balanced against the risk to both mother and child of depression during pregnancy. * __Management of Bipolar Disorder During Pregnancy and the Postpartum Period: Weighing the Risks and Benefits__—Although the onset of bipolar disorder (BP) tends to occur during women's reproductive years, surprisingly little is known about the impact of the menstrual cycle, pregnancy, postpartum, breast-feeding, and menopause on the course and treatment of bipolar disorder. * __Postpartum Mood Disorders__—Women experience a dramatic increase in their risk of developing severe psychiatric illness during postpartum for a full year after delivery. Often overlooked, postpartum disorders must be identified and treated as early as possible to reduce the mother's risk for recurrent and treatment-refractory illness and the child's risk for long-term development problems due to the detrimental effect of maternal depression. * __Use of Antidepressants and Mood Stabilizers in Breast-feeding Women__—This expanded clinical appraisal of the literature on antidepressant and mood stabilizer use in breast-feeding women shows that additional detailed pharmacokinetic investigations are urgently needed to enhance our understanding of nursing infant exposure and the role(s) of pharmacogenomics in determining infant exposure. Meticulously referenced and remarkably succinct, __Mood and Anxiety Disorders During Pregnancy and Postpartum__ provides critical information about the course of illness during pregnancy and postpartum to help guide effective individualized treatment decisions-decisions that are ultimately based on the patient's wishes. Contents 6 Contributors 10 Introduction to the Review of Psychiatry Series 12 Preface 16 Chapter 1 Course of Psychiatric Illness During Pregnancy and the Postpartum 18 Unipolar Depression 19 Bipolar Disorder 21 Anxiety Disorders 22 Psychotic Disorders 25 Risks of Untreated Illness in the Mother 26 Conclusion 27 References 28 Chapter 2 Diagnosis and Treatment of Mood and Anxiety Disorders in Pregnancy 34 Prevalence of Mood and Anxiety Disorders During Pregnancy 36 Risks of Untreated Maternal Illness During Pregnancy 37 Treatment of Mood Disorders During Pregnancy 39 Treatment of Anxiety Disorders During Pregnancy 53 General Guidelines for Treatment of Mood and Anxiety Disorders During Pregnancy 56 Conclusion 58 References 59 Chapter 3 Management of Bipolar Disorder During Pregnancy and the Postpartum Period: Weighing the Risks and Benefits 70 Risk and Course of Bipolar Disorder During Pregnancy 71 Risk and Course of Bipolar Disorder During the Postpartum Period 73 Potential Risks of Pharmacotherapy During Pregnancy 75 Fetal Risks Associated With Mood-Stabilizing Agents 77 Treatment Planning for the Pregnant Patient With Bipolar Disorder 82 Treatment Planning for the Patient With Bipolar Disorder in the Postpartum Period 86 Conclusion 87 References 87 Chapter 4 Postpartum Mood Disorders 94 Clinical Features 96 Screening for Postpartum Mood Disorders 98 Course and Prognosis 100 Risk Factors 100 Treatment 103 Conclusion 112 References 113 Chapter 5 Use of Antidepressants and Mood Stabilizers in Breast-Feeding Women 122 Pharmacologic Treatment Options for Unipolar Depression and Bipolar Disorder in Breast-Feeding 123 Mental Illness in Postpartum Women: Spectrum of Psychiatric Conditions 148 Clinical Decision Making 149 Conclusion 151 References 152 Index 162 A 162 B 162 C 163 D 163 E 163 F 163 G 163 H 163 I 163 L 163 M 164 N 164 O 164 P 164 Q 165 R 165 S 165 T 165 V 165 W 165 Z 165 In Just Five Concise Informative Chapters, The Nine Distinguished Contributors To Mood And Anxiety Disorders During Pregnancy And Postpartum Dispel Prevailing Beliefs And Offer Invaluable Guidance In Treating Women During Pregnancy And The Postpartum Period. They Assert That Pregnancy Is A Time Of Vulnerability To - Rather Than Protection From - Psychiatric Illness, Present Data That Support The Use Of Certain Antidepressants During Pregnancy And Postpartum, Discuss Decisions About What Constitutes Reasonable Risk During Pregnancy, And Call Urgently For Further Studies To Enhance Our Understanding Of Breastfeeding Infant Exposure To Medications.. Meticulously Referenced And Succinct, Mood And Anxiety Disorders During Pregnancy And Postpartum Provides Critical Information About The Course Of Illness During Pregnancy And Postpartum To Help Guide Effective Individualized Treatment Decisions - Decisions That Are Ultimately Based On The Patient's Wishes.--book Jacket. Course Of Psychiatric Illness During Pregnancy And The Postpartum / Laura Fagioli ... [et Al.] -- Diagnosis And Treatment Of Mood And Anxiety Disorders During Pregnancy / Ruta Nonacs ... [et Al.] -- Management Of Bipolar Disorder During Pregnancy And The Postpartum: Weighing The Risks And Benefits / Adele Casals Viguera ... [et Al.] -- Postpartum Mood Disorders / Ruta M. Nonacs -- Use Of Antidepressants And Mood Stabilizers In Breast-feeding Women / Kimberly Ragan... [et Al.]. Edited By Lee S. Cohen, Ruta M. Nonacs. Includes Bibliographical References And Index. The nine distinguished contributors to Mood and Anxiety Disorders During Pregnancy and Postpartum dispel prevailing beliefs and offer invaluable guidance in treating women during pregnancy and the postpartum period. They assert that pregnancy is a time of increased vulnerability to psychiatric illness, present data that support the use of certain antidepressants during pregnancy and postpartum, and discuss decisions about what constitutes "reasonable risk" during pregnancy Diagnosis and treatment of mood and anxiety disorders during pregnancy / Ruta Nonacs ... [et al.] Course of psychiatric illness during pregnancy and the postpartum / Laura Fagioli ... [et al.] Postpartum mood disorders / Ruta M. Nonacs Use of antidepressants and mood stabilizers in breast-feeding women / Kimberly Ragan... [et al.] Management of bipolar disorder during pregnancy and the postpartum: weighing the risks and benefits / Adele Casals Viguera ... [et al.].